Regulation of human sperm motility by opioid receptors

Andrologia. 2012 May:44 Suppl 1:578-85. doi: 10.1111/j.1439-0272.2011.01230.x. Epub 2011 Sep 15.

Abstract

The endogenous opioid system has been reported to have important functions in human reproduction. Practically all the components of this peptide system have been discovered in human sperm cells, but their functions in these cells are far from being well understood. In the present work, we report the effects of opioid agonism and antagonism on human sperm motility, a parameter which is crucially associated with male fertility. Morphine (10(-7) M), a μ- opioid receptor agonist, decreased both the percentage of motile progressive sperm and three measured velocities without altering the linearity, straightness or vigour of sperm cells. This effect was reversed by naloxone. Higher doses of morphine did not have further effects on the measured parameters. The incubation of sperm cells with the δ-opioid receptor agonist D-penicillamine (2,5)-enkephalin did not affect sperm cell motility. However, naltrindole, a specific δ-receptor antagonist, reduced the linear and curvilinear velocities, as well as linearity, straightness and the amplitude of head displacement, and beat frequency. In summary, our results indicate that the endogenous opioid system may regulate opioid motility in vitro. These finding suggest that the endogenous opioid system could be useful as a biochemical tool for the diagnosis and treatment of male infertility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fertility
  • Humans
  • Male
  • Receptors, Opioid / physiology*
  • Sperm Motility*

Substances

  • Receptors, Opioid